ADVERTISEMENT

Canada

Country

Sandoz And Delpharm Renew Canadian Injectables Supply Agreement For 10 Years

Along with financial backing from the Canadian government, a fresh, decade-long partnership with Sandoz Canada will allow Delpharm to carry out modernization plans for its manufacturing facility in Boucherville, securing the local supply chain for sterile injectable medicines.

Celltrion Keeps Pace With Ustekinumab Discounts As It Launches US Stelara Rival

Celltrion has become the latest firm to enter the competitive US market for Stelara biosimilars, revealing details of its Steqeyma launch.

Health Canada Greenlights Kashiv’s Pegfilgrastim Biosimilar

After receiving an approval for the Neulasta rival in the US in May 2022, Kashiv BioSciences has now added a further North American country with a positive nod from Canada’s health agency.

Canada’s New Rare Disease Registry Guidance To Assist Regulatory And HTA Decision Making

Canada’s new guidance on rare disease registries is based on international guidelines, but in some areas there remains work to ensure that implementation of some recommendations is feasible in the Canadian context.

Trump’s Tariffs Likely Miss Political Target While Hitting Bullseye For Economic Impact On US

The president says 4 March would mark the start of tariffs he initially intended to take effect on 1 February before allowing a delay for Mexico and Canada to implement border security to help curb illegal entry by immigrants and fentanyl smuggling.

Cross-Atlantic Alliance Sets Sights On First HTA Methods Recommendations

A new collaboration of health technology appraisal bodies in the US, England and Canada could lead to better alignment on HTA methodology in the future.

‘New’ B+L? Wait Until Bausch Health Sells Stake

Analysts hold back on predicting new heights for B+L until full split from parent firm. It reported Q4 revenue up 9% to $1.28bn and full-year revenue up 16% to $4.79bn.

Apotex Branches Out Into Natural Health With CanPrev Takeover

Canada’s largest generics manufacturer Apotex will look to expand its channels to include health food stores, new professional channels including naturopathic doctors, and grocery retail channels, after acquiring Ontario-based natural health firm CanPrev for an undisclosed sum.

Dr Reddy’s On Semaglutide Canada Opportunity: “We have a good chance”

Dr Reddy’s hopes to be the “first one in the pack”, when Ozempic loses patent cover next year in markets like Canada, where the semaglutide opportunity is projected at $2bn. Openings for the product in 80 smaller markets also loom, it said, but the GLP-1 agonist won’t ‘replace’ generic Revlimid and all business levers will have to grow.

US Nutrition Market News: Anheuser-Busch, TopGum, SameDaySupplements, Resbiotic, More

Anheuser-Busch enters energy drinks space with 1st Phorm; TopGum adds Canadian gummy manufacturer; Resbiotic Nutrition expands distribution to Mexico; SameDaySupplements adds custom Stacks; ‘tailored offerings’ for supplement payment processing; marketing boost for Enroute Nutrition for dietary management of surgery.